arabinofuranosyluracil has been researched along with 5-propynylarabinofuranosyluracil in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (90.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honess, RW; Lacey, SF; Powell, KL; Purifoy, DJ; Suzutani, T | 1 |
| Nikkels, AF; Piérard, GE | 1 |
| Bevilacqua, F; Collins, P; Darby, G; Davis-Poynter, N; Gower, D; Worrallo, J | 1 |
| Crome, P; Holdich, TA; Peck, RW; Posner, J; Weatherley, BC; Wootton, R | 1 |
| Jackson, SH; Lee, DR; Peck, RW; Posner, J; Wootton, R | 1 |
| Easterbrook, P; Wood, MJ | 1 |
| Buick, AR; Cooper, JD; Sheung, CT | 1 |
| Darby, G | 1 |
| Beauchamp, LM; Darby, G; de Miranda, P; Ertl, P; Krenitsky, TA; Lacey, S; Powell, KL; Purifoy, DJ; Rahim, SG; Roberts, G | 1 |
| Bannister, B; Crooks, RJ; Mandal, BK; McKendrick, MW; Peck, RW; Wood, MJ | 1 |
| Buick, AR; Sheung, CT | 1 |
| Callaghan, J; Crome, P; Fraser, I; Frick, L; Peck, R; Posner, J; Wiggs, R; Wootton, R | 1 |
| Bidault, R; Chretien, P; Fillastre, JP; Gillotin, C; Godin, M; Legallicier, B; Peck, RW; Posner, J; Wooton, R | 1 |
| Bidault, R; Fillastre, JP; Godin, M; Le Roy, F; Legallicler, B; Peck, RW; Posner, J | 1 |
| Fiddian, AP | 1 |
| Bannister, B; Crome, P; Crooks, RJ; Mandal, BK; McKendrick, MW; Peck, RW; Wood, MJ | 1 |
| Andersen, PL; Diaz Perez, JL; Fiddian, AP; Lucht, RF; McKendrick, MW; Shukla, S; Söltz-Szöts, J; Tyring, S | 1 |
| Lowe, D; McGuigan, C; Miller, W; Perry, A; Rahim, SG; Slater, MJ; Sutton, PW; Yarnold, CJ | 1 |
| Wareham, D | 2 |
7 review(s) available for arabinofuranosyluracil and 5-propynylarabinofuranosyluracil
| Article | Year |
|---|---|
Recognition and treatment of shingles.
Topics: Acyclovir; Adjuvants, Immunologic; Adrenal Cortex Hormones; Antiviral Agents; Arabinofuranosyluracil; Chickenpox; Herpes Zoster; Humans; Immunoglobulins; Virus Replication | 1994 |
Successors to acyclovir.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Chickenpox; Drug Resistance, Microbial; Famciclovir; Herpes Simplex; Herpes Zoster; Humans; Valacyclovir; Valine | 1994 |
Acyclovir--and beyond.
Topics: Acyclovir; Arabinofuranosyluracil; Cytomegalovirus Infections; Ganciclovir; Guanine; Herpes Simplex; Herpesvirus 3, Human; Humans; Valacyclovir; Valine | 1994 |
Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.
Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Drug Design; Herpesvirus 3, Human; Prodrugs; Valacyclovir; Valine | 1993 |
Antiviral drugs in development for herpes zoster.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Controlled Clinical Trials as Topic; Drug Approval; Famciclovir; Herpes Zoster; Humans; Prodrugs; Treatment Outcome; United States; Valacyclovir; Valine | 1996 |
Postherpetic neuralgia.
Topics: 2-Aminopurine; Acyclovir; Amines; Antidepressive Agents, Tricyclic; Antiviral Agents; Arabinofuranosyluracil; Cyclohexanecarboxylic Acids; Famciclovir; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Neuralgia; Valacyclovir; Valine | 2004 |
Postherpetic neuralgia.
Topics: 2-Aminopurine; Acyclovir; Amines; Antidepressive Agents, Tricyclic; Antiviral Agents; Arabinofuranosyluracil; Cyclohexanecarboxylic Acids; Famciclovir; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuralgia, Postherpetic; Valacyclovir; Valine | 2005 |
6 trial(s) available for arabinofuranosyluracil and 5-propynylarabinofuranosyluracil
| Article | Year |
|---|---|
Pharmacokinetics and tolerability of single oral doses of 882C87, a potent, new anti-varicella-zoster virus agent, in healthy volunteers.
Topics: Administration, Oral; Adult; Aged; Aging; Antiviral Agents; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Fasting; Herpesvirus 3, Human; Humans; Male; Single-Blind Method | 1995 |
The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antiviral Agents; Arabinofuranosyluracil; Biological Availability; Female; Herpesvirus 3, Human; Humans; Male | 1995 |
Inhibition of dihydropyrimidine dehydrogenase by 5-propynyluracil, a metabolite of the anti-varicella zoster virus agent netivudine.
Topics: Aged; Alkynes; Antiviral Agents; Arabinofuranosyluracil; Dihydrouracil Dehydrogenase (NADP); Dose-Response Relationship, Drug; Herpesvirus 3, Human; Humans; Oxidoreductases; Uracil | 1996 |
Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairment.
Topics: Administration, Oral; Aged; Antiviral Agents; Arabinofuranosyluracil; Blood Proteins; Creatinine; Herpesvirus 3, Human; Humans; Male; Middle Aged; Renal Insufficiency | 1996 |
Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Arabinofuranosyluracil; Drug Administration Schedule; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Patient Compliance | 1996 |
A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study Group.
Topics: Acyclovir; Aged; Antiviral Agents; Arabinofuranosyluracil; Double-Blind Method; Drug Administration Schedule; Exanthema; Female; Herpes Zoster; Humans; Male; Middle Aged; Pain; Prognosis | 1998 |
7 other study(ies) available for arabinofuranosyluracil and 5-propynylarabinofuranosyluracil
| Article | Year |
|---|---|
Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Arabinofuranosyluracil; Base Sequence; Cell Line; Cloning, Molecular; DNA, Viral; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Herpesvirus 3, Human; Humans; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Thymidine Kinase; Vero Cells | 1991 |
Construction of a herpes simplex virus/varicella-zoster virus (HSV/VZV) thymidine kinase recombinant with the pathogenic potential of HSV and a drug sensitivity profile resembling that of VZV.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Base Sequence; Cytomegalovirus; Drug Evaluation, Preclinical; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Promoter Regions, Genetic; Thymidine Kinase; Transformation, Genetic; Virulence; Virus Latency | 1995 |
Automated sequential trace enrichment of dialysates combined with high-performance liquid chromatography and automated heart-cutting for the determination of the nucleoside 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil and its metabolite 5-propynylurac
Topics: Alkynes; Antiviral Agents; Arabinofuranosyluracil; Autoanalysis; Chromatography, High Pressure Liquid; Computers; Dialysis; Humans; Indicators and Reagents; Software; Spectrophotometry, Ultraviolet; Uracil | 1994 |
Preliminary pharmacokinetics and safety of 882C87 in patients with herpes zoster.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Arabinofuranosyluracil; Female; Herpes Zoster; Humans; Male; Middle Aged | 1993 |
Determination of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)-uracil and a metabolite, 5-propynyluracil, in plasma using ASTED (automated sequential trace enrichment of dialysates) combined, on-line, with high-performance liquid chromatography.
Topics: Alkynes; Antiviral Agents; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Dialysis; Humans; Reproducibility of Results; Uracil | 1993 |
Pharmacokinetics of netivudine in haemodialysis patients.
Topics: Antiviral Agents; Arabinofuranosyluracil; Humans; Kidney Diseases; Renal Dialysis | 1996 |
Synthesis and evaluation of some masked phosphate esters of the anti-herpesvirus drug 882C (netivudine) as potential antiviral agents.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line; Esterases; Liver; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Phosphates; Prodrugs; Swine | 1998 |